KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcomaYong Kim, Javed Khan, Ranuka Sinniah et al.|Nature Communications|2024Cited by 19
Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a “non-druggable” target, STAT3 N-terminal domainPedro Andrade Bonilla, Nadya I. Tarasova|Frontiers in Oncology|2023Cited by 16
Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a “non-druggable” target, STAT3 N-terminal domainPedro Andrade Bonilla, Nadya I. Tarasova|ChemRxiv|2023Cited by 1
Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a “non-druggable” target, STAT3 N-terminal domainPedro Andrade Bonilla, Nadya I. Tarasova|ChemRxiv|2023Cited by 0